ATI RN
ATI Mental Health Practice A
1. For a patient diagnosed with borderline personality disorder exhibiting self-harming behavior, which therapeutic approach is most appropriate?
- A. Dialectical behavior therapy
- B. Psychoanalysis
- C. Supportive therapy
- D. Pharmacotherapy
Correct answer: A
Rationale: The most appropriate therapeutic approach for a patient diagnosed with borderline personality disorder exhibiting self-harming behavior is dialectical behavior therapy (DBT). DBT is specifically designed to address the core symptoms of borderline personality disorder, including self-harming behaviors. It focuses on teaching patients skills to manage emotions, improve interpersonal relationships, and enhance distress tolerance. Psychoanalysis (Choice B) is not the most appropriate for immediate symptom management in this case. Supportive therapy (Choice C) may not provide the structured approach needed to address self-harming behaviors effectively. Pharmacotherapy (Choice D) may be used as an adjunct in some cases, but DBT is the frontline therapy for managing self-harming behaviors in borderline personality disorder.
2. A patient with agoraphobia is unable to leave home. Which intervention should the nurse prioritize?
- A. Teach the patient relaxation techniques.
- B. Gradual exposure to feared situations.
- C. Encourage the patient to attend social gatherings.
- D. Provide education about the disorder.
Correct answer: B
Rationale: For a patient with agoraphobia, the priority intervention should be gradual exposure to feared situations. This approach helps the patient confront and gradually overcome their fear of leaving home, a common challenge in agoraphobia. By exposing the patient to feared situations in a step-by-step manner, they can learn to manage their anxiety and increase their confidence in leaving home. Teaching relaxation techniques (Choice A) can be beneficial but may not address the core issue of avoidance behavior. Encouraging the patient to attend social gatherings (Choice C) can be overwhelming and counterproductive at the initial stage of treatment. Providing education about the disorder (Choice D) is important but should come after addressing the immediate need for exposure therapy.
3. In assessing a patient for signs of serotonin syndrome, which of the following symptoms would be consistent with this condition?
- A. Hypotension, bradycardia, hypothermia
- B. Hypertension, tachycardia, hyperthermia
- C. Hypotension, tachycardia, hypothermia
- D. Hypertension, bradycardia, hyperthermia
Correct answer: B
Rationale: Serotonin syndrome is characterized by a triad of symptoms: hypertension, tachycardia, and hyperthermia. Therefore, the correct answer is B. Hypotension, bradycardia, and hypothermia (choice A) are not typical findings in serotonin syndrome. Hypotension, tachycardia, and hypothermia (choice C) are also not consistent with serotonin syndrome. Hypertension, bradycardia, and hyperthermia (choice D) do not align with the characteristic symptoms of serotonin syndrome. Recognizing the key symptoms of serotonin syndrome is crucial for prompt identification and intervention to prevent serious complications.
4. When a patient with major depressive disorder is prescribed escitalopram, what potential side effect should the healthcare provider educate the patient about?
- A. Weight gain
- B. Insomnia
- C. Diarrhea
- D. Hypertension
Correct answer: B
Rationale: The correct answer is B: Insomnia. Escitalopram, a selective serotonin reuptake inhibitor (SSRI), commonly causes insomnia as a side effect. Patients should be informed about the possibility of experiencing difficulty falling or staying asleep when starting this medication. Choices A, C, and D are incorrect because weight gain, diarrhea, and hypertension are not typically associated with escitalopram use.
5. A patient with schizophrenia is prescribed clozapine. Which potential side effect requires regular monitoring?
- A. Weight loss
- B. Hypertension
- C. Agranulocytosis
- D. Hyperthyroidism
Correct answer: C
Rationale: When a patient with schizophrenia is prescribed clozapine, regular monitoring for agranulocytosis is essential. Agranulocytosis is a severe reduction in white blood cells that can be life-threatening. Monitoring white blood cell counts is crucial to detect this side effect early and prevent serious complications. Weight loss (Choice A) is not a common side effect of clozapine. Hypertension (Choice B) and hyperthyroidism (Choice D) are also not typically associated with clozapine use, making them incorrect choices for regular monitoring.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 50,000 Questions with answers
- All ATI courses Coverage
- 30 days access @ $69.99
ATI RN Premium
$149.99/ 90 days
- 50,000 Questions with answers
- All ATI courses Coverage
- 30 days access @ $149.99